text: The Aras PLM solution suite is used both as a platform to improve business efficiencies in the educational sector, and to enhance educational curriculum.
  Improve Business Processes: By implementing Aras PLM, educational institutions streamline change management, document management and other common challenges.
  Today’s education institution turns to Aras to improve document management, program management and other key areas.
  As an example, the University of Washington relies on Aras Innovator to streamline processes related to new construction and continuing maintenance demands, with improved access to relevant facilities information to ensure proper management.
  By rethinking the way PLM is designed and deployed, Aras offers a fundamentally different approach. One that quickly adapts to an Educational institution’s way of working and integrates easily with your existing systems
  Aras Innovator is mobile-enabled and is available for deployment as meets requirements - in your data center or in the cloud with defense-grade security and federated integration capabilities
  Aras Innovator is not only used by leading educational institutions as their PLM backbone. The Aras Academic Program gives students hands-on experience with leading edge technology.
  Educational institutions of all kinds can enrich their curriculum with an Aras Academic Subscription - this includes high schools, universities, technical schools and professional schools. The Aras experience is irreplaceable in the undergraduate and graduate level not only for engineering students but also for business, management and computer science students as well.
  Learn how the University of Washington reduces cost while maintaining all information for properties and buildings across the entire campus with Aras
  Based on its recent analysis of the high throughput multiplexing market, Frost & Sullivan recognizes IntelliCyt with the 2016 North American Frost & Sullivan Award for Product [...]
  Delphinus Medical Technologies Inc. is about to graduate. And, after 17 years of research and development and three rounds of venture capital totaling $58.5 million, it will start selling its [...]
  AstraZeneca Enters into an Agreement with IntelliCyt for the Development of High Throughput Biology Applications
  IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody discovery and immuno-oncology research today announced a collaboration with AstraZeneca to further [...]
  NxThera, Inc. announced today that the sexual function preservation data from the Company’s pivotal IDE trial, which previously established the safety and effectiveness of the Rezūm system [...]